 | Did Hedge Funds Make The Right Call On Acceleron Pharma Inc (XLRN) ?
finance.yahoo.com - July 13 at 11:46 PM |
 | Corp /De/ Celgene Sells 2,241 Shares of Acceleron Pharma Inc (NASDAQ:XLRN) Stock
www.marketbeat.com - July 13 at 9:27 PM |
| Acceleron Pharma Inc (NASDAQ:XLRN) to Post Q3 2020 Earnings of ($0.29) Per Share, Piper Sandler Forecasts
www.americanbankingnews.com - July 9 at 7:36 AM |
| Acceleron Pharma Inc (NASDAQ:XLRN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 9 at 6:55 AM |
| Piper Sandler Weighs in on Acceleron Pharma Inc's FY2023 Earnings (NASDAQ:XLRN)
www.americanbankingnews.com - July 8 at 7:12 AM |
| Acceleron Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - July 7 at 5:56 PM |
 | Acceleron Pharma (NASDAQ:XLRN) Given New $130.00 Price Target at Piper Sandler
www.marketbeat.com - July 7 at 7:28 AM |
| Acceleron Pharma (NASDAQ:XLRN) PT Lowered to $130.00
www.americanbankingnews.com - July 7 at 7:27 AM |
| Acceleron Pharma Inc (NASDAQ:XLRN) Major Shareholder Purchases $9,999,990.00 in Stock
www.americanbankingnews.com - July 6 at 8:32 PM |
| Insider Selling: Acceleron Pharma Inc (NASDAQ:XLRN) CEO Sells 50,000 Shares of Stock
www.marketbeat.com - July 6 at 8:32 PM |
|
| XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - July 6 at 5:57 PM |
 | XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm
www.prnewswire.com - July 6 at 5:21 PM |
| Acceleron (XLRN) in Focus: Stock Moves 5.3% Higher
finance.yahoo.com - July 6 at 12:55 PM |
| Acceleron Pharma Inc (NASDAQ:XLRN) Expected to Post Quarterly Sales of $25.06 Million
www.americanbankingnews.com - July 5 at 2:38 AM |
| Analysts Anticipate Acceleron Pharma Inc (NASDAQ:XLRN) to Announce -$0.66 Earnings Per Share
www.americanbankingnews.com - July 3 at 10:02 PM |
 | The Petri Dish: Two new biotech IPOs and a $450M+ licensing deal
www.bizjournals.com - July 2 at 9:32 AM |
| Head to Head Contrast: Acceleron Pharma (NASDAQ:XLRN) vs. Prevail Therapeutics (NASDAQ:PRVL)
www.americanbankingnews.com - July 2 at 8:32 AM |
| 10 Stocks to Invest in the Health Care Revolution
finance.yahoo.com - July 1 at 1:03 PM |
 | Acceleron prices stock offering at $92.50
seekingalpha.com - July 1 at 8:03 AM |
 | Bristol Myers & Acceleron Obtain EC Approval for Reblozyl
www.nasdaq.com - June 29 at 12:48 PM |
| Bristol Myers & Acceleron Obtain EC Approval for Reblozyl
finance.yahoo.com - June 29 at 12:48 PM |
| Acceleron's Sotatercept Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - June 28 at 4:43 PM |
| European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia
finance.yahoo.com - June 26 at 11:40 AM |
| Acceleron Pharma (NASDAQ:XLRN) PT Raised to $132.00 at SVB Leerink
www.americanbankingnews.com - June 26 at 8:29 AM |
| Acceleron's sotatercept successful in mid-stage PAH study
seekingalpha.com - June 25 at 12:51 PM |
| Acceleron Pharma (NASDAQ:XLRN) Price Target Increased to $140.00 by Analysts at Cowen
www.americanbankingnews.com - June 25 at 12:21 PM |
| Royal Bank of Canada Boosts Acceleron Pharma (NASDAQ:XLRN) Price Target to $99.00
www.americanbankingnews.com - June 25 at 10:19 AM |
| Credit Suisse Group Raises Acceleron Pharma (NASDAQ:XLRN) Price Target to $134.00
www.americanbankingnews.com - June 25 at 10:19 AM |
| Acceleron Pharma (NASDAQ:XLRN) Stock Rating Reaffirmed by Oppenheimer
www.americanbankingnews.com - June 25 at 6:21 AM |
| Acceleron's sotatercept successful on mid-stage PAH study
seekingalpha.com - June 24 at 8:10 PM |
|
| Acceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension
finance.yahoo.com - June 24 at 8:10 PM |
| Acceleron Pharma stock jumps after positive heart-drug study
finance.yahoo.com - June 24 at 8:10 PM |
| Acceleron conference call Wednesday on mid-stage study of sotatercept in PAH
seekingalpha.com - June 22 at 1:04 PM |
| Acceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020 Virtual Conference
finance.yahoo.com - June 22 at 8:03 AM |
| Stock Traders Buy High Volume of Call Options on Acceleron Pharma (NASDAQ:XLRN)
www.americanbankingnews.com - June 19 at 3:26 PM |
| Acceleron (XLRN) Down 6.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 10 at 1:49 PM |
| Acceleron Appoints Christopher Hite to its Board of Directors
finance.yahoo.com - June 4 at 6:55 PM |
| Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN)
finance.yahoo.com - June 1 at 5:33 PM |
| Acceleron Announces Presentations on REBLOZYL® (luspatercept-aamt) at the 2020 American Society of Clinical Oncology and European Hematology Association Virtual Annual Meetings
finance.yahoo.com - May 20 at 8:10 AM |
| Acceleron Announces Oral Presentation of PULSAR Phase 2 Trial Results in Virtual American Thoracic Society 2020 Conference Session on June 24, 2020
finance.yahoo.com - May 19 at 1:44 PM |
| Acceleron Announces Publication in Science Translational Medicine Describing the Underlying Biology Behind Sotatercept’s Potential as a Novel Therapy in Pulmonary Arterial Hypertension
finance.yahoo.com - May 13 at 6:35 PM |
| Acceleron Pharma Inc (XLRN) Q1 2020 Earnings Call Transcript
www.nasdaq.com - May 12 at 9:20 PM |
| Acceleron (XLRN) Q1 Loss Wider Than Expected, Revenues Miss
finance.yahoo.com - May 12 at 4:17 PM |
| Edited Transcript of XLRN earnings conference call or presentation 11-May-20 9:00pm GMT
finance.yahoo.com - May 12 at 4:17 PM |
| Acceleron Pharma (XLRN) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 11 at 10:12 PM |
| Acceleron Pharma EPS misses by $0.09, misses on revenue
seekingalpha.com - May 11 at 5:11 PM |
| Acceleron Reports First Quarter 2020 Operating and Financial Results
finance.yahoo.com - May 11 at 5:11 PM |
| Acceleron Pharma Q1 2020 Earnings Preview
seekingalpha.com - May 10 at 9:52 PM |
| Acceleron to Webcast First Quarter 2020 Operating and Financial Results on May 11, 2020
finance.yahoo.com - May 5 at 9:47 AM |
| EMA grants PRIME designation to Acceleron's sotatercept
seekingalpha.com - May 4 at 1:10 PM |
